Evidence map›Paper›PMID 22508985›Full record

ArticleMolecular and cellular biology2012

Nucleosome remodeler SNF2L suppresses cell proliferation and migration and attenuates Wnt signaling.

Maren Eckey, Silke Kuphal, Tobias Straub, Petra Rümmele, Elisabeth Kremmer, Anja K Bosserhoff, Peter B Becker

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 38 citations in OpenAlex.

  1. Tuning epigenetics to enhance cancer virotherapy.Acta pharmaceutica Sinica. B · 2026
    Review
  2. Article
  3. Review
  4. Nonsurgical treatment reduces tendon inflammation and elevates tendon markers in early healing.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2022
    Article
  5. Hypermethylation ofEXCLI journal · 2022
    Article
  6. The emerging role of ISWI chromatin remodeling complexes in cancer.Journal of experimental & clinical cancer research : CR · 2021
    Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Maren EckeyAdolf Butenandt Institute, Center for Integrated Protein Science (CIPSM), Ludwig Maximilian University, Munich, Germany.
Silke Kuphal
Tobias Straub
Petra Rümmele
Elisabeth Kremmer
Anja K Bosserhoff
Peter B Becker
University of Regensburg · DECenter for Integrated Protein Science Munich · DEHelmholtz Zentrum München · DELudwig-Maximilians-Universität München · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ISWI is an evolutionarily conserved ATPase that catalyzes nucleosome remodeling in different macromolecular complexes. Two mammalian ISWI orthologs, SNF2H and SNF2L, are thought to have specialized functions despite their high sequence similarity. To date, the function of SNF2L in human cells has not been a focus of research. Newly established specific monoclonal antibodies and selective RNA interference protocols have now enabled a comprehensive characterization of loss-of-function phenotypes in human cells. In contrast to earlier results, we found SNF2L to be broadly expressed in primary human tissues. Depletion of SNF2L in HeLa cells led to enhanced proliferation and increased migration. These phenomena were explained by transcriptome profiling, which identified SNF2L as a modulator of the Wnt signaling network. The cumulative effects of SNF2L depletion on gene expression portray the cell in a state of activated Wnt signaling characterized by increased proliferation and chemotactic locomotion. Accordingly, high levels of SNF2L expression in normal melanocytes contrast with undetectable expression in malignant melanoma. In summary, our data document an inverse relationship between SNF2L expression and features characteristic of malignant cells.

Indexed as

Cell ProliferationAdenosine TriphosphatasesAntibodies, MonoclonalAntibody SpecificityBase Sequencebeta CateninCell AdhesionCell Line, TumorCell MovementChromosomal Proteins, Non-HistoneDNA-Binding ProteinsFemaleGene Expression ProfilingGene Knockdown TechniquesHeLa CellsHumansAdenosine TriphosphatasesAntibodies, Monoclonalbeta CateninChromosomal Proteins, Non-HistoneCTNNB1 protein, humanDNA-Binding ProteinsNucleosomesRNA, Small InterferingSMARCA1 protein, humanSMARCA5 protein, humanTranscription Factors

Identifiers

PMID22508985
PMCPMC3434487
OpenAlexW2018114690

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.